drugset / Trial / NCT01028963
A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the safety and potential effectiveness of CCX140-B in subjects with Type 2 diabetes mellitus.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-10
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CCX140-B | Small molecule | — | — |
| Comparator | Pioglitazone | Small molecule | 30 mg | — |